On 29 November 2024, we will focus on virus-based therapies and highlight the status, future opportunities and challenges of these new, promising therapeutic approaches.

 

The event will cover various aspects ranging from market developments and the current research landscape on virus-based biopharmaceuticals to industrial-scale studies for their production and clinical application - always with patients in mind.

 

The event is aimed at researchers, developers and engineers from industry and academia, young scientists, doctors and anyone interested in this rapidly growing therapeutic field.

Registration is still possible via the event website.